Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Italo Tempera

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV associated gastric cancerSarah Preston-Alp, Yin Wang, Matteo Bergonzoni, et al.
Biochemical Pharmacology|November 12, 2018
Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cellsVirginia Correani, Sara Martire, Giuseppina Mignogna, et al.
Nature Communications|January 18, 2022
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activitySarah M Morgan, Hideki Tanizawa, Lisa Beatrice Caruso, et al.
Mbio|February 10, 2026
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancerSarah Preston-Alp, Yin Wang, Matteo Bergonzoni, et al.
Acta Diabetologica|June 14, 2017
Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studiesAlessandra Giorgi, Italo Tempera, Giorgia Napoletani, et al.
Blood Advances|January 4, 2018
MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugsSilvia Maifrede, Esteban Martinez, Margaret Nieborowska-Skorska, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC AxisGiorgia Napoletani, Samantha S Soldan, Toshitha Kannan, et al.
Virology|April 30, 2017
PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoterLena N Lupey-Green, Stephanie A Moquin, Kayla A Martin, et al.
Plos Pathogens|August 5, 2021
EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytesChenhe Su, Fang Lu, Samantha S Soldan, et al.
Journal of Medical Virology|July 7, 2025
PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC AxisLisa Beatrice Caruso, Giorgia Napoletani, Samantha S Soldan, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|November 24, 2025
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV associated gastric cancerSarah Preston-Alp, Yin Wang, Matteo Bergonzoni, et al.
Biochemical Pharmacology|November 12, 2018
Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cellsVirginia Correani, Sara Martire, Giuseppina Mignogna, et al.
Nature Communications|January 18, 2022
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activitySarah M Morgan, Hideki Tanizawa, Lisa Beatrice Caruso, et al.
Mbio|February 10, 2026
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancerSarah Preston-Alp, Yin Wang, Matteo Bergonzoni, et al.
Acta Diabetologica|June 14, 2017
Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studiesAlessandra Giorgi, Italo Tempera, Giorgia Napoletani, et al.
Blood Advances|January 4, 2018
MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugsSilvia Maifrede, Esteban Martinez, Margaret Nieborowska-Skorska, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC AxisGiorgia Napoletani, Samantha S Soldan, Toshitha Kannan, et al.
Virology|April 30, 2017
PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoterLena N Lupey-Green, Stephanie A Moquin, Kayla A Martin, et al.
Plos Pathogens|August 5, 2021
EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytesChenhe Su, Fang Lu, Samantha S Soldan, et al.
Journal of Medical Virology|July 7, 2025
PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC AxisLisa Beatrice Caruso, Giorgia Napoletani, Samantha S Soldan, et al.
Pageof 7